Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors.

[1]  Victor W. Pike,et al.  Improved syntheses of the PET radioligands, [11C]FLB 457, [11C]MDL 100907 and [11C]β‐CIT‐FE, by the use of [11C]methyl triflate , 1998 .

[2]  Christer Halldin,et al.  A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients , 1997, Psychopharmacology.

[3]  G. Sedvall,et al.  Autoradiographic comparison of [125I]epidepride and [125I]NCQ 298 binding to human brain extrastriated dopamine receptors. , 1997, Nuclear medicine and biology.

[4]  H. Wikström,et al.  Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635 , 1997, Brain Research.

[5]  C. Halldin,et al.  Preparation of [76Br]FLB 457 and [76Br]FLB 463 for examination of striatal and extrastriatal dopamine D-2 receptors with PET. , 1996, Nuclear medicine and biology.

[6]  Christer Halldin,et al.  Autoradiographic localization of extrastriatal D2‐dopamine receptors in the human brain using [125I]epidepride , 1996, Synapse.

[7]  T Suhara,et al.  Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  Christer Halldin,et al.  Radioligand Disposition and Metabolism — Key Information in Early Drug Development , 1995 .

[9]  K Wienhard,et al.  The ECAT EXACT HR: Performance of a New High Resolution Positron Scanner , 1994, Journal of computer assisted tomography.

[10]  Christer Halldin,et al.  Metabolism of the PET ligand [11C]SCH 23390. Identification of two radiolabelled metabolites with HPLC , 1994 .

[11]  Robert M. Kessler,et al.  Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride , 1993, Brain Research.

[12]  J R Votaw,et al.  Visualization of extrastriatal dopamine D2 receptors in the human brain. , 1992, European journal of pharmacology.

[13]  R. G. Manning,et al.  Preparation of [123I]‐ and [125I]epidepride: A dopamine D‐2 receptor antagonist radioligand , 1991 .

[14]  K. Neve,et al.  Characterization and distribution of [125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain. , 1991, The Journal of pharmacology and experimental therapeutics.

[15]  G. Sedvall,et al.  Autoradiography with saturation experiments of 11C-Ro 15–1788 binding to human brain sections , 1991, Journal of Neuroscience Methods.

[16]  H. Kung,et al.  Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents. , 1990, Journal of medicinal chemistry.

[17]  T. Högberg,et al.  Potential antipsychotic agents 5. Synthesis and antidopaminergic properties of substituted 5,6-dimethoxysalicylamides and related compounds. , 1990, Journal of medicinal chemistry.

[18]  H. Hall,et al.  Potential antipsychotic agents. Part 8. Antidopaminergic properties of a potent series of 5-substituted (−)-(S)-N-[(1-ethylpyrrolidin-2-yl)methyl]-2,3-dimethoxybcnzaimides. Synthesis via common lithio intermediates† , 1990 .

[19]  G. Sedvall,et al.  Carbon-11 labelling of eticlopride in two different positions--a selective high-affinity ligand for the study of dopamine D-2 receptors using PET. , 1990, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[20]  C. Halldin,et al.  Syntheses of [123I]-, [125I]- and unlabelled (S)-3-iodo-5,6-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]salicylamide (NCQ 298), selective ligands for the study of dopamine D-2 receptors. , 1990, Acta pharmaceutica Nordica.